SHOSHANA YUDKOWSKY: Open Payments
NPI 1841760550 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 70 payments from 22 companies in 2025. Trend: 2023 $1,330 · 2024 $2,200 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $226 |
| AstraZeneca Pharmaceuticals LP | 5 | $191 |
| Lilly USA, LLC | 14 | $135 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $89 |
| ABBVIE INC. | 3 | $77 |
| Inspire Medical Systems, Inc. | 2 | $58 |
| PFIZER INC. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $47 |
Products named: Ozempic, AIRSUPRA, TZIELD, Kerendia, MOUNJARO, JARDIANCE, INSPIRE, FARXIGA.
Industry payments across MD — which companies pay providers there.
